PT968717E - Preparacao sob a forma galenica simples visando limitar os efeitos ocorridos durante a menopausa, e posteriormente, e tratamento com esta preparacao - Google Patents

Preparacao sob a forma galenica simples visando limitar os efeitos ocorridos durante a menopausa, e posteriormente, e tratamento com esta preparacao

Info

Publication number
PT968717E
PT968717E PT99450012T PT99450012T PT968717E PT 968717 E PT968717 E PT 968717E PT 99450012 T PT99450012 T PT 99450012T PT 99450012 T PT99450012 T PT 99450012T PT 968717 E PT968717 E PT 968717E
Authority
PT
Portugal
Prior art keywords
preparation
aims
treatment
limit
occurring during
Prior art date
Application number
PT99450012T
Other languages
English (en)
Inventor
Jack Auzerie
Original Assignee
Amistad Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amistad Pharma Sas filed Critical Amistad Pharma Sas
Publication of PT968717E publication Critical patent/PT968717E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT99450012T 1998-06-02 1999-06-02 Preparacao sob a forma galenica simples visando limitar os efeitos ocorridos durante a menopausa, e posteriormente, e tratamento com esta preparacao PT968717E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807051A FR2779062A1 (fr) 1998-06-02 1998-06-02 Preparation sous forme galenique simple visant a limiter les effets induits durant la menopause et posterieurement et traitement avec cette preparation

Publications (1)

Publication Number Publication Date
PT968717E true PT968717E (pt) 2006-09-29

Family

ID=9527031

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99450012T PT968717E (pt) 1998-06-02 1999-06-02 Preparacao sob a forma galenica simples visando limitar os efeitos ocorridos durante a menopausa, e posteriormente, e tratamento com esta preparacao

Country Status (7)

Country Link
EP (1) EP0968717B1 (pt)
AT (1) ATE328597T1 (pt)
DE (1) DE69931696T2 (pt)
DK (1) DK0968717T3 (pt)
ES (1) ES2267241T3 (pt)
FR (1) FR2779062A1 (pt)
PT (1) PT968717E (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013464A1 (en) * 2004-07-27 2006-02-09 Amistad Pharma Sas Hormone replacement therapy comprising a combination of 17-beta-oestradiol and chlormadinone acetate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (pt) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE4019670A1 (de) * 1990-06-22 1992-01-09 Erhard Dr Med Roemer Arzneimittel zur behandlung der wechseljahre der frau
SE9403389D0 (sv) * 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster

Also Published As

Publication number Publication date
DE69931696D1 (de) 2006-07-20
FR2779062A1 (fr) 1999-12-03
DK0968717T3 (da) 2006-08-14
EP0968717B1 (fr) 2006-06-07
ES2267241T3 (es) 2007-03-01
ATE328597T1 (de) 2006-06-15
EP0968717A1 (fr) 2000-01-05
DE69931696T2 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
NZ229310A (en) 4-(quinolin-2-ylmethoxy) phenylacetic acid derivatives and pharmaceutical compositions
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
CA2387873A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
LV10907A (lv) Interferona polietilenglikola atvasinajums
EP0988862A3 (en) Formulation for use in immunisation
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
FI990134A (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
AU3587797A (en) Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin
GB2134786A (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
EE200000056A (et) 4-okso-3,5-dihüdro-4H-püridasino[4.5-b]indool-1-etaanamiidi derivaadid, nende valmistamine ja kasutamine raviks
SE9402880D0 (sv) New peptide derivatives
NO172439C (no) Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten
EP0369216A3 (en) Pharmaceutical preparation based on ester derivatives of hecogenine, and their use in treating benign prostatic hyperplasia
PT968717E (pt) Preparacao sob a forma galenica simples visando limitar os efeitos ocorridos durante a menopausa, e posteriormente, e tratamento com esta preparacao
SE8600496L (sv) Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider
AU8962191A (en) A process for the preparation of a pasteurized and iron-free human transferrin and the use thereof
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
CA2325282A1 (en) Use of apo b secretion/mtp inhibitors